Phase 3 trial results for an oral GLP-1 medication demonstrated significant improvement in type 2 diabetes management, building on injectable drug success.
Tag: Oral
Oral GLP-1 Drug for Type 2 Diabetes Shows Major Blood Sugar and Weight Loss in Trial
A new once-daily oral semaglutide variant delivered significant reductions in blood glucose and body weight in a major phase 3 clinical trial.
New Oral GLP-1 Medication Shows Dramatic Blood Sugar and Weight Loss in Major Clinical Trial
A landmark trial reveals an oral version of GLP-1 medication dramatically improves blood sugar control and drives significant weight loss in type 2 diabetes.